Variation in Human Papillomavirus Vaccine Uptake and Acceptability Between Female and Male Adolescents and Their Caregivers
- 395 Downloads
HPV vaccination coverage is suboptimal. Previous research largely focused on vaccinating girls. This study aimed to identify factors associated with HPV vaccination among male and female adolescents. We conducted secondary analyses using the National Immunization Survey-Teen. We specified parallel logistic models to examine associations of adolescent, caregiver, and provider characteristics with vaccination status among boys and girls. The primary outcome was HPV vaccination status defined as unvaccinated, initiated, or completed. Additionally, we analyzed caregivers’ intent to initiate or complete the three-dose series. The vaccination completion rate was 26 %. Among teens aged 13–17 years, 19 % initiated, but did not complete the vaccine. Additionally, 14 % of males completed the 3-dose series as compared to 38 % of females. Vaccination rates were higher among teens receiving a provider recommendation [girls: adjusted odds ratio (AOR) = 3.33, 95 % confidence interval (CI) (2.44, 4.55); boys: AOR = 10.0, 95 % CI (7.69, 12.5)]. Moreover, provider recommendation was associated with caregivers’ intent to initiate vaccination [girls: AOR = 2.32, 95 % CI (1.77, 3.02); boys: AOR = 2.76, 95 % CI (2.22, 3.43)]. Other associations differed by gender. Higher vaccine initiation rates were associated with younger age and residing in the mid-west for girls and racial/ethnic minority and eligibility for the “Vaccine for Children” program for boys. Provider recommendation for vaccination was the strongest predictor for both genders; however, it is insufficient to achieve high coverage rates, especially among boys. Factors associated with HPV vaccination were different for males and females. These findings suggest providers should consider gender bias with regard to HPV vaccination.
KeywordsHPV vaccination Gender Adolescents Secondary data
Compliance with Ethical Standards
Conflict of interest
The Authors declare that there is no conflict of interest. This research was conducted as a doctoral student project and was not supported by any funding sources.
- 1.Saslow, D., et al. (2007). American Cancer Society guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors. C CA: A Cancer Journal for Clinicians, 57(1), 7–28.Google Scholar
- 4.Centers for Disease Control and Prevention. (2010). FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). MMWR Morbidity and Mortality Weekly Report, 59(20), 626–629.Google Scholar
- 7.Statistics, N.C.f.H. (2013). Health, United States, 2013: With special feature on prescription drugs.Google Scholar
- 8.Centers for Disease Control and Prevention. (2013). National and state vaccination coverage among adolescents aged 13–17 years–United States, 2012. MMWR Morbidity and Mortality Weekly Report, 62(34), 685–93.Google Scholar
- 11.Elam-Evans, L. D., Yankey, D., Jeyarajah, J., Singleton, J. A., Curtis, R. C., MacNeil, J., Hariri, S. (2014). National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 years—United States, 2013. MMWR Morbidity and Mortality Weekly Report, 63(29), 625–633.PubMedGoogle Scholar
- 15.Wang, E., et al. (2014). Nonmedical exemptions from school immunization requirements: A systematic review. American Journal of Public Health, 101, e1–e23.Google Scholar
- 17.CDC.(2012). Vaccination coverage among children in kindergarten—United States, 2011–12 school year. MMWR. Morbidity and Mortality Weekly Report, 61(33), 647–652.Google Scholar
- 31.Chicago, N.a.t.U.o. (2012). National immunization survey-teen: A user’s guide for the 2012 public-use data file, C.f.D.C.a. Prevention, Editor.Google Scholar
- 33.Ojha, R. P., et al. (2013). The accuracy of human papillomavirus vaccination status based on adult proxy recall or household immunization records for adolescent females in the United States: Results from the National Immunization Survey-Teen. Annals of Epidemiology, 23(5), 281–285.CrossRefPubMedGoogle Scholar
- 38.CDC. (2012) Vaccines for children program. http://www.cdc.gov/vaccines/programs/vfc/index.html.
- 39.Gilkey, M. B., et al. (2015). Quality of physician communication about human papillomavirus vaccine: Findings from a national survey. Cancer Epidemiology, Biomarkers & Prevention: A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology, 24(11), 1673–1679.CrossRefGoogle Scholar